Latest News about APLS
Recent news which mentions APLS
From Benzinga
Apellis' Pegcetacoplan Showed Continuous, Meaningful Effects At Month 18 In Geographic Atrophy Studies
March 16, 2022
Tickers
APLS
From Benzinga
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
From Benzinga
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
From Benzinga
What 9 Analyst Ratings Have To Say About Apellis Pharmaceuticals
December 08, 2021
Tickers
APLS
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
December 08, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
November 29, 2021
From Benzinga
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
November 16, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 15, 2021
From Benzinga
Cramer Likes DraftKings, Skyworks, And These Automakers
October 07, 2021
From Benzinga
Is Good News Enough for You to Buy NGM on the Dip?
October 06, 2021
From Motley Fool
Raymond James Upgraded This Biopharma Stock And Sees 44% Upside
September 13, 2021
From Benzinga
60 Biggest Movers From Friday
September 13, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Slides Over 100 Points; Echo Global Logistics Shares Spike Higher
September 10, 2021
From Benzinga
What 11 Analyst Ratings Have To Say About Apellis Pharmaceuticals
September 10, 2021
Tickers
APLS
From Benzinga
8 Health Care Stocks With Unusual Options Alerts In Today's Session
September 10, 2021
From Benzinga
Tickers
APLS
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.